Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Food Funct ; 11(6): 5525-5537, 2020 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-32515775

RESUMO

The aim of this study is to investigate the beneficial effects of whole mung bean (WMB) and decorticated mung bean (DMB) on the regulation of serum glucose and lipid disorders in high-fat diet (HFD) and streptozotocin (STZ)-induced prediabetic mice, and to further explore their gut microbiota modulatory effects. In the present study, the ability of mung bean-based diets to combat prediabetes-related metabolic disorders was determined by assessing the changes in the physiological, biochemical, and histological parameters, and the gut microbiota composition of prediabetic mice. The supplementation of both WMB and DMB can effectively alleviate HFD and STZ-induced impaired glucose tolerance (P < 0.05), which was accompanied by improvements in pancreatic ß-cell damage and hepatic steatosis. However, only WMB supplementation significantly decreased the fasting blood glucose and fasting serum insulin levels by sensitizing insulin action (P < 0.05), and reduced the serum lipid profiles and glycosylated serum protein levels (P < 0.05). Furthermore, high-throughput pyrosequencing of the 16S rRNA gene revealed that WMB and DMB supplementation could prevent HFD and STZ-induced gut microbiota dysbiosis, especially for the enrichment of some benign bacteria, such as Bifidobacterium and Akkermansia, and the reduction of some harmful bacteria (Staphylococcus and Enterococcus). Overall, although decortication processing had an impact on the beneficial effects of mung bean, it did not cause the loss of all health benefits.


Assuntos
Dieta Hiperlipídica/efeitos adversos , Microbioma Gastrointestinal/fisiologia , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Estreptozocina/efeitos adversos , Vigna , Animais , Glicemia , Diabetes Mellitus Tipo 2 , Disbiose/microbiologia , Ingestão de Alimentos , Microbioma Gastrointestinal/genética , Intolerância à Glucose , Insulina/metabolismo , Metabolismo dos Lipídeos , Lipídeos , Fígado/metabolismo , Fígado/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Estado Pré-Diabético , RNA Ribossômico 16S
2.
Meat Sci ; 164: 108094, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32146297

RESUMO

The aim of this study was to investigate the effect of spirulina supplementation in a high-energy (HE) diet on lipid metabolism, oxidative status and immunity in Hu lambs. The lambs were assigned to two groups receiving either a standard diet (ST) or a HE diet. Each group was divided into three subgroups: no spirulina supplementation (control), 1% spirulina supplementation, or 3% spirulina supplementation. The body fat, serum cholesterol, triacylglycerol and oxidative stress increased in lambs fed the HE diet. However, 3% spirulina supplementation in the HE diet reduced above parameters and enhanced antioxidant capacity, including increased SOD activity and T-AOC content in serum and Longissimus thoracis et lumborum (LTL). Additionally, lambs receiving 3% spirulina supplementation showed an improvement in immunity-related parameters, including increased IgG concentration in serum and red and white blood cell counts. In conclusion, 3% spirulina supplementation in HE diet ameliorated lipid metabolic disorder and oxidative stress caused by a HE diet.


Assuntos
Dieta/veterinária , Transtornos do Metabolismo dos Lipídeos/veterinária , Carneiro Doméstico/metabolismo , Spirulina , Ração Animal/análise , Animais , Contagem de Células Sanguíneas/veterinária , Colesterol/sangue , Dieta/efeitos adversos , Imunoglobulina G/sangue , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/radioterapia , Músculo Esquelético , Estresse Oxidativo , Distribuição Aleatória , Carneiro Doméstico/imunologia , Triglicerídeos/sangue
3.
Nutrients ; 12(1)2020 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-31941004

RESUMO

Menopause is clinically diagnosed as a condition when a woman has not menstruated for one year. During the menopausal transition period, there is an emergence of various lipid metabolic disorders due to hormonal changes, such as decreased levels of estrogens and increased levels of circulating androgens; these may lead to the development of metabolic syndromes including cardiovascular diseases and type 2 diabetes. Dysregulation of lipid metabolism affects the body fat mass, fat-free mass, fatty acid metabolism, and various aspects of energy metabolism, such as basal metabolic ratio, adiposity, and obesity. Moreover, menopause is also associated with alterations in the levels of various lipids circulating in the blood, such as lipoproteins, apolipoproteins, low-density lipoproteins (LDLs), high-density lipoproteins (HDL) and triacylglycerol (TG). Alterations in lipid metabolism and excessive adipose tissue play a key role in the synthesis of excess fatty acids, adipocytokines, proinflammatory cytokines, and reactive oxygen species, which cause lipid peroxidation and result in the development of insulin resistance, abdominal adiposity, and dyslipidemia. This review discusses dietary recommendations and beneficial compounds, such as vitamin D, omega-3 fatty acids, antioxidants, phytochemicals-and their food sources-to aid the management of abnormal lipid metabolism in postmenopausal women.


Assuntos
Transtornos do Metabolismo dos Lipídeos , Metabolismo dos Lipídeos/fisiologia , Menopausa/fisiologia , Pós-Menopausa/fisiologia , Adulto , Idoso , Estrogênios/deficiência , Ácidos Graxos Ômega-3 , Feminino , Humanos , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/fisiopatologia , Pessoa de Meia-Idade , Obesidade , Compostos Fitoquímicos , Probióticos , Vitamina D
4.
Lipids ; 53(1): 53-63, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29488640

RESUMO

N6 -methyladenosine (m6 A) regulates gene expression and affects cellular metabolism. In this study, we checked whether the regulation of lipid metabolism by curcumin is associated with m6 A RNA methylation. We investigated the effects of dietary curcumin supplementation on lipopolysaccharide (LPS)-induced liver injury and lipid metabolism disorder, and on m6 A RNA methylation in weaned piglets. A total of 24 Duroc × Large White × Landrace piglets were randomly assigned to control, LPS, and CurL (LPS challenge and 200 mg/kg dietary curcumin) groups (n = 8/group). The results showed that curcumin reduced the increase in relative liver weight as well as the concentrations of aspartate aminotransferase and lactate dehydrogenase induced by LPS injection in the plasma and liver of weaning piglets (p < 0.05). The amounts of total cholesterol and triacylglycerols were decreased by curcumin compared to that by the LPS injection (p < 0.05). Additionally, curcumin reduced the expression of Bcl-2 and Bax mRNA, whereas it increased the p53 mRNA level in the liver (p < 0.05). Curcumin inhibited the enhancement of SREBP-1c and SCD-1 mRNA levels induced by LPS in the liver. Notably, dietary curcumin affected the expression of METTL3, METTL14, ALKBH5, FTO, and YTHDF2 mRNA, and increased the abundance of m6 A in the liver of piglets. In conclusion, the protective effect of curcumin in LPS-induced liver injury and hepatic lipid metabolism disruption might be due to the increase in m6 A RNA methylation. Our study provides mechanistic insights into the effect of curcumin in protecting against hepatic injury during inflammation and metabolic diseases.


Assuntos
Curcumina/administração & dosagem , Inflamação/dietoterapia , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Fígado/efeitos dos fármacos , Adenosina/análogos & derivados , Adenosina/metabolismo , Animais , Metilação de DNA/efeitos dos fármacos , Metilação de DNA/genética , Metabolismo Energético/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Inflamação/induzido quimicamente , Inflamação/metabolismo , Inflamação/veterinária , Metabolismo dos Lipídeos/efeitos dos fármacos , Transtornos do Metabolismo dos Lipídeos/induzido quimicamente , Transtornos do Metabolismo dos Lipídeos/metabolismo , Transtornos do Metabolismo dos Lipídeos/veterinária , Lipopolissacarídeos/toxicidade , Fígado/metabolismo , Fígado/patologia , RNA Mensageiro/genética , Transdução de Sinais/efeitos dos fármacos , Estearoil-CoA Dessaturase/genética , Proteína de Ligação a Elemento Regulador de Esterol 1/genética , Suínos , Triglicerídeos/metabolismo , Desmame
5.
Clín. investig. arterioscler. (Ed. impr.) ; 29(6): 239-247, nov.-dic. 2017. tab
Artigo em Inglês | IBECS | ID: ibc-169581

RESUMO

Background: Knowledge about the harmful effects of high levels of low-density lipoprotein cholesterol (cLDL) in adults increased after the publication of various guidelines, leading to closer control and more treatment. We hypothesized that these health care changes would result in an overall improvement in the lipid profile of the population. Objective: To determine the evolution of the lipid profile in the population of Spain from the Diet and Risk of Cardiovascular Disease in Spain cohort. Methods: A comparison was made between the baseline population-based probabilistically sampled DRECE cohort (DRECE 1 study, 1992-1994, n=4787) and its 13 years later revisit (DRECE 3 study, 2005-2007). A cross-sectional comparison was made of the overall population of DRECE1 and DRECE3, including only individuals aged 20 to 60 years (inter-individual variations). For subjects participating in both DRECE1 and DRECE3 (n=1039), individual variations over time (intra-individual analyses) were examined. Results: In the overall population, the prevalence of lipid-lowering therapy increased from 3.8% in DRECE1 to 10.7% in DRECE3. Comparing the lipid profile of the population aged 20-60 years in DRECE1 with the same age group in DRECE3, an overall decrease is observed in total cholesterol from a mean of 203.31mg/dl (SD 43.51) in 1992-1994 to 196.31mg/dl (SD 38.53) in 2005-2007, and in cLDL from a mean of 125.78mg/dl (SD 38.53) to 121.37mg/dl (SD 34.22). The proportion of the population with total cholesterol >200mg/dl decreased from 51% in DRECE1 to 47% in DRECE3, although this difference did not reach statistical significance (p=0.077). As regards the intra-individual analyses, total cholesterol increased from DRECE1 to DRECE3 in men and women younger than 40 years at baseline, but decreased in those who were older. Index of individuality for total cholesterol, cLDL, cHDL and triglycerides ranged from 0.53 to 0.87. Conclusions: The lipid profile of the Spanish population improved between 1992-1994 and 2005-2007. Within individuals, lipid concentrations, especially total cholesterol and cLDL have increased, although the trend is favorable in the middle-age group (40-59 years). These changes seem to be due to several causes, impacted by dietary and lifestyle factors, and also by a greater emphasis in lipid-lowering therapy in middle-aged people. Lipid parameters had a low index of individuality, which limits their usefulness as population reference values (AU)


Antecedentes: Los efectos nocivos de los altos niveles de colesterol ligado a lipoproteínas de baja densidad (cLDL) han sido ampliamente difundidos en la literatura científica y popular. Nuestra hipótesis es que estas recomendaciones han influido eficazmente en el perfil lípido de la población española. Objetivo: Determinar la evolución del perfil de lípidos en la población de España a partir de la cohorte Dieta y riesgo de enfermedad cardiovascular en España (DRECE). Métodos: Se comparó la cohorte de partida DRECE (estudio DRECE1, 1992-1994, n=4.787), procedente de muestreo probabilístico poblacional, con su reevaluación a los 13 años (estudio DRECE3, 2005-2007). Se compararon de modo transversal las muestras DRECE1 y DRECE3, incluyendo solo sujetos entre 20 y 60 años (variaciones interindividuales). De los sujetos que participaron en ambos estudios (n=1.039) se examinaron las variaciones interindividuales a lo largo del tiempo (análisis intraindividual). Resultados: En la población general, la prevalencia de la terapia hipolipidemiante aumentó de 3,8% en DRECE1 a 10,7% en DRECE3. Al comparar el perfil lipídico de la población de 20 a 60 años en DRECE1 con el mismo grupo de edad en DRECE3 disminuye la media del colesterol total de 203,31mg/dl (DS 43,51) en 1992-1994 a 196,31mg/dl (DS 38,53) en 2005-2007, la media del cLDL disminuye de 125,78mg/dl (DS 38,53) a 121,37mg/dl (DS 34,22). La proporción de la población con colesterol total>200mg/dl se redujo de 51% en DRECE1 al 47% en DRECE3, aunque esta diferencia no fue significativa (p=0,077). Respecto del análisis intraindividual el colesterol total aumentó de DRECE1 a DRECE3 en hombres y mujeres menores de 40 años al inicio de la cohorte, y descendió en los mayores de 40. El índice de individualidad del colesterol total, cLDL, cHDL y triglicéridos osciló entre 0,53 y 0,87. Conclusiones: El perfil lipídico de la población española mejoró entre 1992-1994 y 2005-2007. La concentración intraindividual de lípidos aumentó ligeramente, especialmente el colesterol total y cLDL, pero la tendencia fue más favorable en los sujetos de edad media (40-59 años). Estos cambios parecen ser multicausales, influidos por factores dietéticos y de estilo de vida, y también por un mayor énfasis en la terapia hipolipidemiante en sujetos en edad media. Los parámetros lipídicos tenían un bajo índice de individualidad, lo que limita su utilidad como valores de referencia poblacionales (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Lipídeos/análise , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/prevenção & controle , Colesterol/análise , Triglicerídeos/análise , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Dieta Mediterrânea , Estudos de Coortes , 28599 , Transtornos do Metabolismo dos Lipídeos/diagnóstico
6.
Curr Med Chem ; 21(24): 2729-33, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24606524

RESUMO

Alterations of lipid metabolism have been increasingly recognized as a hallmark of cancer cells. Cancer cells esterify fatty acids predominantly to phospholipids, an essential component of cell membranes. The main pathway along which proliferating cells gain lipids for membrane synthesis is the endogenous mevalonate pathway. Increased synthesis of mevalonate and mevalonate-derived isoprenoids supports increased cell proliferation through activating growth-regulatory proteins and oncoproteins and promoting DNA synthesis. The importance of a better knowledge of metabolic changes in lipogenic enzymes pathways, as well as of the role of each biochemical pathway in carcinogenesis, provides the rationale for in-depth study of the oncogenic signaling important for the initiation and progression of tumors. The dependence of tumor cells on a dysregulated lipid metabolism suggests that the proteins involved in this process may be excellent chemotherapeutic targets for cancer treatment. Here, we confirm the vital link between lipogenesis and cell proliferation, and our recent findings suggest that nutritional intervention is an effective and safe way to reduce cell proliferation in experimental models of carcinogenesis. The olive oil diet significantly reduces the protein activities of lipogenic enzymes associated with cell growth. The use of natural dietary components could potentially assist in the management of subjects with metabolic disorders-related tumors.


Assuntos
Metabolismo dos Lipídeos , Neoplasias/metabolismo , Neoplasias/patologia , Animais , Proliferação de Células/efeitos dos fármacos , Gorduras Insaturadas na Dieta/administração & dosagem , Gorduras Insaturadas na Dieta/farmacologia , Gorduras Insaturadas na Dieta/uso terapêutico , Humanos , Transtornos do Metabolismo dos Lipídeos/complicações , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/tratamento farmacológico , Transtornos do Metabolismo dos Lipídeos/metabolismo , Neoplasias/complicações , Neoplasias/dietoterapia , Neoplasias/tratamento farmacológico , Azeite de Oliva , Óleos de Plantas/administração & dosagem , Óleos de Plantas/farmacologia , Óleos de Plantas/uso terapêutico
7.
Nutrients ; 4(11): 1781-93, 2012 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-23201848

RESUMO

In the present study, we used a preclinical model of induced lipolytic enzyme insufficiency, and hypothesized that the use of monoacylglycerols (MAG) will enhance their bioavailability and delivery to the tissues. Experimental diets containing 20% lipids were fed to rats for 21 days with or without Orlistat. The control diet of fish oil (FO), a source of EPA and DHA, was tested against: structured (A) vanillin acetal of sn-2 MAG (Vanil + O) and (B) diacetyl derivative of sn-2 MAG (Acetyl + O) and (C) free MAG (MAG + O). FA profiles with an emphasis on EPA and DHA levels were determined in plasma, red blood cells (RBC), liver, spleen, brain and retina. We observed significant reduction of lipid absorption when rats co-consumed Orlistat. As expected, the FO groups with and without Orlistat showed the biggest difference. The Vanil + O, Acetyl + O and MAG + O groups, demonstrated higher levels of EPA (5.5 ± 1.9, 4.6 ± 1.6 and 5.6 ± 0.6, respectively) in RBC compared with FO + O diets (3.3 ± 0.2, 2.6 ± 0.2). Levels of EPA incorporation, in plasma, were similar to those obtained for RBC, and similar trends were observed for the collected tissues and even with DHA levels. These observations with two MAG derivatives providing the fatty acid esterified in the sn-2 position, show that these molecules are efficient vehicles of EPA in malabsorption conditions which is in line with our hypothesis. Free MAG, characterized as having exclusively sn-1(3) isomers of EPA, demonstrated better absorption efficiencies and accretion to tissues when compared to structured MAG. The study demonstrated that structured and free MAG can be used efficiently as an enteral vehicle to supply bioactive fatty acids such as EPA and DHA in lipid malabsorption where diminished lipolytic activity is the underlying cause.


Assuntos
Ácido Eicosapentaenoico/administração & dosagem , Ácido Eicosapentaenoico/farmacocinética , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Síndromes de Malabsorção/dietoterapia , Monoglicerídeos/administração & dosagem , Animais , Disponibilidade Biológica , Gorduras na Dieta/administração & dosagem , Modelos Animais de Doenças , Ácidos Docosa-Hexaenoicos/administração & dosagem , Ácidos Docosa-Hexaenoicos/sangue , Ácidos Docosa-Hexaenoicos/farmacocinética , Sistemas de Liberação de Medicamentos , Ácido Eicosapentaenoico/sangue , Eritrócitos/química , Óleos de Peixe/administração & dosagem , Lactonas , Lipase/antagonistas & inibidores , Masculino , Orlistate , Ratos , Ratos Wistar
9.
Pró-fono ; 21(4): 291-297, out.-dez. 2009. tab
Artigo em Inglês, Português | LILACS | ID: lil-536794

RESUMO

BACKGROUND: different etiologies are related to tinnitus including metabolic disorders (blood glucose and lipids). AIM: the aim of this study was compare tinnitus severity by self-report measures pre and post nutritional intervention, using the Tinnitus Handicap Inventory. METHOD: participants of this study were twenty one male and female subjects, with ages ranging from 40 to 82 years. Inclusion criteria involved the presence of tinnitus and metabolic disorder diagnosed by laboratory exams. All subjects were submitted to a nutritional intervention program. Audiological evaluation and the Tinnitus Handicap Inventory were applied pre and post intervention. RESULTS: when comparing the presence of tinnitus pre and post intervention, data analysis indicates statistical difference concerning tinnitus sensation - 71.5 percent of the individuals referred less impact of tinnitus in daily activities. CONCLUSION: an important difference was observed concerning tinnitus influence in subject's life by self-report measures. A direct relation between tinnitus and metabolic disorders in cases related with this symptom was verified.


TEMA: diferentes etiologias estão relacionadas com a presença de zumbido, incluindo doenças metabólicas (glicêmicas e lipídicas). OBJETIVO: comparar o grau de severidade do zumbido por meio de medidas de auto-análise em sujeitos com alterações metabólicas pré e pós-intervenção nutricional, utilizando o Questionário de Gravidade do Zumbido. MÉTODO: vinte e um sujeitos, homens e mulheres, com idade entre 40 e 82 anos, participaram deste estudo. Critérios de inclusão abrangeram a presença de zumbido e de alteração metabólica diagnosticada por meio de exames laboratoriais. Todos os sujeitos foram submetidos a um programa de intervenção nutricional. A avaliação audiológia e o questionário de gravidade de zumbido foram aplicados pré e pós-intervenção. RESULTADOS: comparando os resultados pré e pós-intervenção os dados mostram uma diferença estatisticamente significante com relação à sensação do zumbido em 71,5 por cento dos sujeitos, os quais referiram menor impacto do zumbido nas atividades diárias. CONCLUSÃO: uma importante diferença foi observada com relação à influência do zumbido na vida do sujeito quando utilizadas as medidas de auto-análise. Verificou-se uma relação direta entre zumbido e alterações metabólicas em casos relacionados a estes sintomas.


Assuntos
Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos do Metabolismo de Glucose/complicações , Transtornos do Metabolismo dos Lipídeos/complicações , Zumbido/etiologia , Transtornos do Metabolismo de Glucose/dietoterapia , Transtornos do Metabolismo de Glucose/metabolismo , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/metabolismo , Fatores de Tempo
10.
Pro Fono ; 21(4): 291-7, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20098946

RESUMO

BACKGROUND: Different etiologies are related to tinnitus including metabolic disorders (blood glucose and lipids). AIM: The aim of this study was compare tinnitus severity by self-report measures pre and post nutritional intervention, using the Tinnitus Handicap Inventory. METHOD: Participants of this study were twenty one male and female subjects, with ages ranging from 40 to 82 years. Inclusion criteria involved the presence of tinnitus and metabolic disorder diagnosed by laboratory exams. All subjects were submitted to a nutritional intervention program. Audiological evaluation and the Tinnitus Handicap Inventory were applied pre and post intervention. RESULTS: When comparing the presence of tinnitus pre and post intervention, data analysis indicates statistical difference concerning tinnitus sensation--71.5% of the individuals referred less impact of tinnitus in daily activities. CONCLUSION: An important difference was observed concerning tinnitus influence in subject's life by self-report measures. A direct relation between tinnitus and metabolic disorders in cases related with this symptom was verified.


Assuntos
Transtornos do Metabolismo de Glucose/complicações , Transtornos do Metabolismo dos Lipídeos/complicações , Zumbido/etiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Transtornos do Metabolismo de Glucose/dietoterapia , Transtornos do Metabolismo de Glucose/metabolismo , Humanos , Transtornos do Metabolismo dos Lipídeos/dietoterapia , Transtornos do Metabolismo dos Lipídeos/metabolismo , Masculino , Pessoa de Meia-Idade , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...